Characterising cardiac stent coating thickness, structural integrity, and quality
Cardiac stents, especially drug-eluting fully biodegradable stents, offer patients a quick, effective, and non-invasive method of treating coronary heart disease. Product innovation within stent research and development and manufacturing is strong, with a range of bio-engineered coatings, materials, and designs under development all with the aim of improving product reliability and efficacy, and promoting post-operative recovery.
However constant innovation and pressure to develop the next generation of stents brings with it a suite of manufacturing and conformance challenges, many of which are not easily addressed using existing technologies. Fundamentals such as degradation of physical integrity over time, blood flow optimisation, drug distribution, flexibility, influence of heat, cold and humidity, restenosis rate, in-patient performance and ease of manufacture all have to be addressed individually and concurrently to create novel products that will be attractive to the market.
Customers for whom the above factors are potential sources of competitive advantage will find n-eos’ technology and products ideally suited to supporting all aspects of the research and development and manufacturing process, as well as helping meet regulatory standards.
Advantages of Our Technology
n-eos’ offers those involved in the research and development, manufacture, or regulatory approval of all forms of cardiac stents with a ground breaking new technique that offers a host of significant and measurable benefits. Affordable, real time and repeatable characterisation of any stent sample can now be conducted quickly and reliably, directly influencing ease of manufacture, in-patient performance, and product quality.